Current role
Andrea DiFabio
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrea DiFabio
The proxy statement of Xenon Pharmaceuticals Inc. reports total compensation of $3,062,790 for Andrea DiFabio in fiscal 2025, including a base salary of $510,000. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Xenon Pharmaceuticals Inc. (XENE)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Xenon Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Ian Mortimer CEO, Chief Accounting Officer, Board Member
- Simon Pimstone Chairman
- Thomas (Tucker) Kelly CFO
- Thomas Kelly CFO
- Tucker Kelly CFO
- Clarissa Desjardins Board Member
- Dawn Svoronos Board Member
- Dr. Clarissa Desjardins Board Member
- Dr. Gillian Cannon Board Member
- Elizabeth Garofalo Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xenon Pharmaceuticals Inc. (XENE) | Chief Legal Officer and Corporate Secretary | $510,000 | $3,062,790 |
| 2024 | Xenon Pharmaceuticals Inc. (XENE) | Chief Legal Officer and Corporate Secretary | $490,000 | $4,104,490 |
| 2023 | Xenon Pharmaceuticals Inc. (XENE) | Chief Legal Officer and Corporate Secretary | $460,000 | $1,721,162 |
| 2022 | Xenon Pharmaceuticals Inc. (XENE) | Chief Legal Officer and Corporate Secretary | $68,365 | $3,552,950 |
Recent activity
No call appearances or filed executive changes recorded yet.